跳转到主要内容
  • 关于 ELGA
    • 关于 ELGA
    • 超纯水
    • 纯化技术
    • 水中杂质
    • 白皮书
    • 认证合作伙伴
    • 可持续发展
    • 降低临床风险
    • 招贤纳士
    • 活动
    • HPLC 的制药应用
    • HPLC 水纯度
  • 博客
    • Analytical Chemistry
    • Clinical & Pharma
    • Cool Science
    • Environment and sustainability
    • Life in the lab
    • Purelab product design
    • Science of the future
    • Water Purity
    • Water in the lab
  • 联系信息
  • English
  • Deutsch
  • Español
  • Français
  • Italiano
  • Português
  • 日本語
首页 ELGA LabWater
  • 产品
  • 应用
  • 案例分析
  • 支持
  • 产品
    • PURELAB
    • CENTRA
    • MEDICA
    • BIOPURE
    • ELGA 全产品系列
  • 应用
  • 案例分析
    • 借助超纯水,解开南极的秘密
    • 1+ 级超纯水对非专利药物开发的重要性
    • Ca’Foscari University- A New Method for Investigating Environmental Tracers in Ice
    • Ca’Foscari University- Investigating Contaminants in Antarctic Ice
    • DASA:巴西最大的医疗诊断公司
    • ELGA 帮助免疫血清学实验室最大程度地增加运行时间
    • Optimale Wasserqualität für mikrobiologische Forschung und Lehre
    • PURELAB® flex:适合当今研究方法的理想培训系统
    • Sichere Reinstwasserversorgung für präzise Produkttests
    • Zentrale Reinstwasser-Aufbereitung für Analyser
    • 城市综合医院为西门子 ADVIA® 分析仪选配 MEDICA® Pro
    • 雅培诊断的南亚团队选用 ELGA MEDICA 系统
  • 支持
    • 支持和服务
    • 实验室规划
    • 注册产品
    • Register Your Product (USA & Canada Only)
  • 产品
    • PURELAB
      • PURELAB Chorus 1 Complete
      • PURELAB® Chorus 1
      • PURELAB Chorus 2+
      • PURELAB® Chorus 2
      • PURELAB® Chorus 3
      • PURELAB® flex 1 & 2
      • PURELAB® flex 3 & 4
    • CENTRA
      • CENTRA® 60/120
      • CENTRA® RDS
      • CENTRA® R200
    • MEDICA
      • MEDICA® 7/15
      • MEDICA® EDI 15/30
      • MEDICA® Pro EDI 60/120
      • MEDICA® Pro-LPS
      • MEDICA® Pro-R 和 Pro-RE
      • MEDICA® R200
    • BIOPURE
      • BIOPURE 7/15
      • BIOPURE 60/120
      • BIOPURE 200/300/600
    • ELGA 全产品系列
      • PURELAB® Classic
  • 应用
  • 案例分析
    • 借助超纯水,解开南极的秘密
    • 1+ 级超纯水对非专利药物开发的重要性
    • Ca’Foscari University- A New Method for Investigating Environmental Tracers in Ice
    • Ca’Foscari University- Investigating Contaminants in Antarctic Ice
    • DASA:巴西最大的医疗诊断公司
    • ELGA 帮助免疫血清学实验室最大程度地增加运行时间
    • Optimale Wasserqualität für mikrobiologische Forschung und Lehre
    • PURELAB® flex:适合当今研究方法的理想培训系统
    • Sichere Reinstwasserversorgung für präzise Produkttests
    • Zentrale Reinstwasser-Aufbereitung für Analyser
    • 城市综合医院为西门子 ADVIA® 分析仪选配 MEDICA® Pro
    • 雅培诊断的南亚团队选用 ELGA MEDICA 系统
  • 支持
    • 支持和服务
    • 实验室规划
    • 注册产品
    • Register Your Product (USA & Canada Only)
  • English
  • Deutsch
  • Español
  • Français
  • Italiano
  • Português
  • 日本語
  • 隐私政策
  • 条款和条件
  • 全球法律合规
  • 专利
  • 页面操作员
  • 首页
  • Node
  • Identifying Anti-Viral Compounds In Chinese Medicinal Herbs
Clinical & Pharma
Cool Science

Identifying Anti-Viral Compounds In Chinese Medicinal Herbs

1 3月 2020
- by Dr Alison Halliday

Chinese Herbs

Using a new knowledge-based high-throughput screening strategy, researchers isolate three compounds with potent anti-viral activity from herbal extracts used in traditional medicine.

With people travelling more frequently and living in more densely populated areas, the potential for infectious diseases to spread rapidly and cause a pandemic is a major concern. Indeed, the serious global health threat posed by emerging viral infections is highlighted through recent outbreaks such as Ebola, Zika and Dengue.

The challenge is how to prepare for the future, since we don’t know when or where a new outbreak may occur – or the identity of the infectious agent. We need to build an arsenal of potent new anti-viral drugs to combat the risk of global pandemics with unpredictable viruses.

With around a third of all modern medicines are derived from natural products, many researchers are now turning to herbal remedies used in ancient medical practices as a source of new lead compounds for drug discovery.

Discovering Drugs From Traditional Medicines

Traditional Chinese Medicine (TCM) originated in ancient China and has evolved over thousands of years. Its practitioners use herbal medicines combined with various mind and body practices to treat or prevent health problems.

Herbal extracts used in TCM may contain a wealth of potentially valuable anti-viral compounds. But as most formulations contain a blend of multiple components, isolating an individual bioactive constituent is a daunting and labour-intensive process – with a low probability of success.

Integrating knowledge from ancient healing practices could help improve current high-throughput screening strategies – accelerating progress in discovering useful compounds from traditional herbal remedies.

Data-Driven Drug Discovery

A new study, published in Pharmacological Research, used a new ‘knowledge-based’ screening strategy and showed that this approach can efficiently identify anti-viral lead compounds from complex herbal extracts.1

The researchers systematically mined knowledge about herbal remedies and their therapeutic applications from the ‘Shanghan Zabing Lun’, an ancient TCM treatise containing over 200 formulations. Using a process of rational evaluation, they selected 24 formulations with potential anti-viral activity – and six more as negative controls. The team then used chromatography to separate these into fractions, creating a herbal extract library of 1,306 different components.

From Hit To Lead Compound

The team then screened each fraction for anti-viral activity using a high-throughput cell-based assay, identifying 18 components derived from seven ‘hit’ TCM formulations with different relieving effects on the symptoms of colds or influenza. Noticeably, none of the active components was derived from the six negative controls.

Using high-performance liquid-chromatography-mass spectrometry (HPLC/MS) Western blotting and immunofluorescence, the researchers went on to identify three lead compounds with potential anti-viral activity: ononin, sec-O-β-D-glucosylhamaudol and astragaloside I. 

The researchers used an ELGA PURELAB® laboratory water purification system to generate the ultrapure water that they used in their experiments.

A Powerful New Strategy

This study identifies three new promising anti-viral drug candidates and also provides proof-of-principle for an alternative screening approach for unearthing anti-viral lead compounds from TCM. This new targeted drug discovery approach could be extended to various cell-based models related to other diseases, helping to accelerate the process of identifying bioactive constituents from complex traditional formulations.

Why Choose ELGA LabWater?

ELGA’s expert engineers, chemists and scientists are at the forefront of technological innovation. We continue to introduce game-changing features to the laboratory water market.

 

Reference:

  1. Yu Y. et al. Ononin, sec-O-β-D-glucosylhamaudol and astragaloside I: anti-viral lead compounds identified via high throughput screening and biological validation from traditional Chinese medicine Zhongjing formulary. Pharmacol Res 2019; 145: 104248.

 

Dr Alison Halliday
After completing an undergraduate degree in Biochemistry & Genetics at Sheffield University, Alison was awarded a PhD in Human Molecular Genetics at the University of Newcastle. She carried out five years as a Senior Postdoctoral Research Fellow at UCL, investigating the genes involved in childhood obesity syndrome. Moving into science communications, she spent ten years at Cancer Research UK engaging the public about the charity’s work. She now specialises in writing about research across the life sciences, medicine and health.

 

  • Enquiry
  • 获取报价
  • 预订演示
  • 联系获认证的合作伙伴

Enquiry

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

获取报价

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

预订演示

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

Elga LabWater 总部

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
United Kingdom
电话: +44 (0) 203 567 7300
传真:+44 (0) 203 567 7205

超纯水专家

  • 支持和服务
  • 活动

案例研究

  • 雅培诊断
  • DASA 医学诊断
  • NeoDIN 医学研究所
  • 北斯塔福德郡 NHS 信托大学医院
  • Olsberg 职业技术学院

资源

  • 了解超纯水
  • 白皮书
  • 水纯化技术
  • 实验室应用
  • 水中杂质

Blogs

  • Latest Blog
  • Water Purity - Different Types of Pure Water
  • What is Clinical Laboratory Reagent Water (CLSI)?
  • What is Total Organic Carbon (TOC)?
  • 语言
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • Veolia 其他站点
    • Veolia
    • Veolia Fondation
    • Veolia Water Technologies

© VWS (UK) Ltd. 以 ELGA®LabWater 的名义经营业务。2021- 保留所有权利
ELGA 是 Veolia 旗下全球实验室用水品牌。

  • 隐私政策
  • 条款和条件
  • 全球法律合规
  • 专利
  • 页面操作员
Elga Veolia
TOP

© 2017 ELGA Veolia